Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Leukemia
|
July 1, 1996
Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines
F Gieseler, A Glasmacher, D Kämpfe, et al.
Advances in Biochemical Engineering/Biotechnology
|
September 1, 2012
Adult mesenchymal stem cells explored in the dental field
K M Fawzy El-Sayed, C Dörfer, F Fändrich, et al.
Scandinavian Journal of Immunology
|
July 20, 2007
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition
P Wrobel, H Shojaei, B Schittek, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 31, 2001
Correlation between the expression of DNA topoisomerases I and IIalpha and clinical parameters in kidney disease
L V Ivanova, P Rudolph, Y M Shilov, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 7, 2002
Thrombin as a survival factor for cancer cells: thrombin activation in malignant effusions in vivo and inhibition of idarubicin-induced cell death in vitro
H Schiller, T Bartscht, A Arlt, et al.
Leukemia & Lymphoma
|
January 28, 1999
In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants
V Nüssler, R Pelka-Fleisc, F Gieseler, et al.
Hamostaseologie
|
October 17, 2007
[Coagulation and formation of malignant effusions]
F Gieseler, B Stelck, L-F Blume, et al.
Annals of Hematology
|
January 1, 1994
Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal
V Nüssler, R Pelka-Fleischer, H Zwierzina, et al.
British Journal of Haematology
|
April 1, 1997
Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells
B Wyler, Y Shao, E Schneider, et al.
Leukemia
|
January 22, 1998
Oral idarubicin, dexamethasone and vincristine (VID) in the treatment of multiple myeloma
A Glasmacher, T Haferlach, M Gorschlüter, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Leukemia
|
July 1, 1996
Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines
F Gieseler, A Glasmacher, D Kämpfe, et al.
Advances in Biochemical Engineering/Biotechnology
|
September 1, 2012
Adult mesenchymal stem cells explored in the dental field
K M Fawzy El-Sayed, C Dörfer, F Fändrich, et al.
Scandinavian Journal of Immunology
|
July 20, 2007
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition
P Wrobel, H Shojaei, B Schittek, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 31, 2001
Correlation between the expression of DNA topoisomerases I and IIalpha and clinical parameters in kidney disease
L V Ivanova, P Rudolph, Y M Shilov, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 7, 2002
Thrombin as a survival factor for cancer cells: thrombin activation in malignant effusions in vivo and inhibition of idarubicin-induced cell death in vitro
H Schiller, T Bartscht, A Arlt, et al.
Leukemia & Lymphoma
|
January 28, 1999
In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants
V Nüssler, R Pelka-Fleisc, F Gieseler, et al.
Hamostaseologie
|
October 17, 2007
[Coagulation and formation of malignant effusions]
F Gieseler, B Stelck, L-F Blume, et al.
Annals of Hematology
|
January 1, 1994
Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal
V Nüssler, R Pelka-Fleischer, H Zwierzina, et al.
British Journal of Haematology
|
April 1, 1997
Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells
B Wyler, Y Shao, E Schneider, et al.
Leukemia
|
January 22, 1998
Oral idarubicin, dexamethasone and vincristine (VID) in the treatment of multiple myeloma
A Glasmacher, T Haferlach, M Gorschlüter, et al.
Page
of 5